Publication details
Second-line treatment with gefitinib (Iressa, ZD 1839) in patient with advanced non-small-cell lung cancer.
| Authors | |
|---|---|
| Year of publication | 2003 |
| Type | Article in Proceedings |
| Conference | Woorkbook of Iressa Clinical Experience Meeting |
| MU Faculty or unit | |
| Citation | |
| Field | Pneumology |
| Keywords | non-small-cell lung cancer; gefitinib treatment; antitumour activity; |
| Description | A case is presented of a 73-year old female non-smoker with advanced, symptomatic NSCLC, initially treated with gemcitabine and carboplatin, but improved only after oral gefitinib 250mg/day, which was well tolerated and demonstrated good antitumour activity. |
| Related projects: |